A Review of Carbamazepine's Hematologic Reactions and Monitoring Recommendations
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Early case reports of fatal hematologic effects attributed to carbamazepine (CBZ) resulted in extensive monitoring recommendations by the manufacturer. The rarity of blood dyscrasias led many authors to question the manufacturer's guidelines. Thus the manufacturer removed specific monitoring guidelines, allowing physicians to monitor CBZ using their clinical judgment. This article reviews case reports and studies of CBZ's hematologic effects. Due to their rapid onset, daily laboratory checks would be necessary to monitor for aplastic anemia, agranulocytosis, and thrombocytopenia. These adverse effects are best monitored by informing patients and physicians to carefully watch for signs and symptoms. Leukopenia develops more slowly, occurring in approximately 12 percent of children and 7 percent of adults. Its onset is typically within the first three months of treatment, with patients at risk having a low or low-normal pretreatment white blood cell (WBC) count. Leukopenia often reverses, even if CBZ is continued. Based upon our review of the literature, we recommend monitoring of those high-risk patients during the first three months of treatment with the frequency being determined by results of each laboratory value. WBC counts <3000/mm 3 or neutrophil counts below 1000/mm 3 warrant a decrease in dose with frequent monitoring or CBZ discontinuation, if necessary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Use of Phenytoin and Carbamazepine in the Treatment of Epilepsy
Ramsay, R. E. (1986) · Neurologic Clinics · doi:10.1016/s0733-8619(18)30964-2 · Cited by 18
Cited by
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.3.413 · Cited by 112
Dols, A., Sienaert, P., van Gerven, H., Schouws, S., Stevens, A., Kupka, R., & Stek, M. L. (2013) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32836435e2 · Cited by 86
(2001) · PubMed · Cited by 59
Metadata
- Authors
- Sobotka, J. L., Alexander, B., & Cook, B. L.
- Venue
- DICP
- Publisher
- SAGE Publications
- Published
- 1990-12
- Volume
- 24
- Issue
- 12
- Pages
- 1214-1219
- ISSN
- 1042-9611 (ISSN-L)
- OpenAlex
- W2123892364
- Cited by
- 80
- References
- 1
- FWCI
- 0.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Review of Carbamazepine's Hematologic Reactions and Monitoring Recommendations. https://app.cochat.ai/papers/10.1177/106002809002401214
- The paper
- Sobotka, J. L., Alexander, B., & Cook, B. L. (1990). A Review of Carbamazepine's Hematologic Reactions and Monitoring Recommendations. DICP. https://doi.org/10.1177/106002809002401214
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.